Evidence map›Paper›PMID 42177555›Full record

ArticleJournal of translational medicine2026

AI-assisted radiomics for classification of benign and non-benign right heart masses in 2D-echocardiography.

Yan Chen, Mengqing Deng, Linyuan Xie, Huiling Cheng, Jiali Wu, Anqi Yang, Yun Mou, Shenjiang Hu

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yan ChenEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Mengqing DengEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Linyuan XieEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Huiling ChengEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jiali WuEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Anqi YangEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yun MouEchocardiography and Vascular Ultrasound Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 1193047@zju.edu.cn.
Shenjiang HuDepartment of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, No.79, Qing-Chun Road, Hangzhou, 310003, China. hzhzl85519933@zju.edu.cn.

Funding

the Major Scientific and Technological Innovation Project of Hangzhou 2022AIZD0065
6 · The paper itself

Abstract

backgroundThe rarity of right heart masses challenges diagnostic proficiency, while reproducibility is affected by the echocardiography operator. Artificial intelligence (AI)-based imaging tools may help address these limitations.

methodsIn this retrospective study (2013-2024), we enrolled surgical patients with right heart masses and obtained preoperative transthoracic (TTE) and transesophageal (TEE) echocardiographic images. Two-dimensional (2D) TTE (n = 98) and TEE (n = 87) images underwent radiomics analysis. Binary classification models were developed to differentiate benign from non-benign lesions using five machine-learning (ML) algorithms (decision trees, logistic regression, random forests, support vector machines (SVMs), extreme gradient boosting (XGBoost)). ML performance was compared with that of a deep-learning model based on the residual network (ResNet)-18 architecture using standard evaluation metrics such as the area under the curve (AUC).

resultsIn 2D TTE analysis, ResNet-18 achieved the highest AUC (0.889), followed by XGBoost (0.836) and decision tree (0.815). ResNet-18 significantly outperformed SVM (P = 0.013) and logistic regression (P = 0.028), but showed no significant differences versus XGBoost (P = 0.408), decision tree (P = 0.429), or random forest (P = 0.053). In 2D TEE analysis, SVM achieved the highest AUC (0.959), followed by XGBoost (0.924) and random forest (0.906), with no significant differences among these models (all P > 0.05). ResNet-18 (AUC = 0.900) significantly outperformed only the decision tree (P = 0.027).

conclusionResNet-18 showed the highest TTE AUC and outperformed SVM and logistic regression, but was comparable to other ML models. SVM achieved the highest TEE AUC, with no significant differences among top models. These findings provide a preliminary AI benchmark for right heart mass diagnosis, though external validation is needed.

Indexed as

Artificial IntelligenceEchocardiographyHeart NeoplasmsRadiomicsArea Under CurveBoosting Machine Learning AlgorithmsClassification AlgorithmsFemaleHumansLogistic ModelsMachine LearningRandom ForestRetrospective StudiesROC CurveSupport Vector MachineDeep learningDifferential diagnosisEchocardiographyMachine learningRight heart masses

Identifiers

PMID42177555
PMCPMC13412137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.